Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

SEC Filings

RSS RSS Feeds
Form 10-K
MERIDIAN BIOSCIENCE INC filed this Form 10-K on 12/01/2014
Document Outline
Entire Document (2897.1 KB)
Subdocument 1 - 10-K - ANNUAL REPORT
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - N/A
Page 4 - BUSINESS
Page 5 - Diagnostics Segment
Page 6 - illumi
Page 7 - Market Trends
Page 8 - EMEA
Page 9 - Helicobacter pylori
Page 10 - Research and Development
Page 11 - Government Regulation
Page 12 - Life Science Segment
Page 13 - Market Trends
Page 14 - Manufacturing and Government Regulation
Page 15 - RISK FACTORS
Page 16 - Revenues for our Diagnostics segment may be impacted by our reliance upon two key distributors in No
Page 17 - We could be adversely affected by health care reform legislation.
Page 18 - Intense competition could adversely affect our profitability.
Page 19 - Risks Affecting our Manufacturing Operations
Page 20 - Finished Products
Page 21 - Product infringement claims by other companies could result in costly disputes and could limit our a
Page 22 - Our bank credit agreement imposes restrictions with respect to our operations.
Page 23 - Natural disasters, war and other events could adversely affect our future revenues and operating inc
Page 24 - LEGAL PROCEEDINGS
Page 25 - MARKET FOR REGISTRANT S COMMON
Page 26 - MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL
Page 27 - REVENUE OVERVIEW
Page 28 - N/A
Page 29 - Revenue Overview- By Product Platform/Type
Page 30 - illumi
Page 31 - Diagnostics Revenue Overview- By Disease Family
Page 32 - Respiratory Products
Page 33 - Operating Expenses:
Page 34 - Fiscal 2014
Page 35 - Operating Income
Page 36 - Impact of Inflation
Page 37 - Capital Resources
Page 38 - Known Contractual Obligations:
Page 39 - Concentration of Customers/Products Risk
Page 40 - illumi
Page 41 - Intangible Assets
Page 42 - Recent Accounting Pronouncements:
Page 43 - Presentation of Financial Statements Going Concern (Subtopic 205-40),
Page 44 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Page 45 - Management s Report on Internal Control over Financial Reporting
Page 46 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 47 - N/A
Page 48 - CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Page 49 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (dollars in thousands)
Page 50 - CONSOLIDATED STATEMENTS OF CASH FLOWS (dollars in thousands)
Page 51 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 52 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 53 - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (dollars and shares in thousands, except per share da
Page 54 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 55 - N/A
Page 56 - illumi
Page 57 - illumi
Page 58 - illumi
Page 59 - N/A
Page 60 - (2) Inventories
Page 61 - (4) Income Taxes
Page 62 - N/A
Page 63 - (5) Employee Benefits
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - (6) Non-Current Liabilities
Page 68 - illumi
Page 69 - N/A
Page 70 - (8) Commitments and Contingencies
Page 71 - (9) Quarterly Financial Data (Unaudited)
Page 72 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Page 73 - EQUITY COMPENSATION PLAN INFORMATION
Page 74 - EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Page 75 - N/A
Page 76 - N/A
Page 77 - N/A
Page 78 - Year Ended September 30, 2014:
Subdocument 2 - EX-10.10 - EX-10.10
Page 1 - Exhibit 10.10
Page 2 - FY 2015 Published Net Earnings Guidance Range Diluted EPS of $******
Page 3 - N/A
Subdocument 3 - EX-10.12 - EX-10.12
Page 1 - Exhibit 10.12
Page 2 - 3. Forfeiture of Restricted Units.
Page 3 - 6. Voting and Other Rights.
Page 4 - 15. Section 409A of the Code.
Page 5 - 21. Language.
Subdocument 4 - EX-10.13 - EX-10.13
Page 1 - Exhibit 10.13
Page 2 - 3. Forfeiture of Restricted Units
Page 3 - seventh
Page 4 - 12. Adjustments
Page 5 - 20. Governing Law
Subdocument 5 - EX-13 - EX-13
Page 1 - Exhibit 13
Page 2 - CORPORATE PROFILE
Page 3 - Corporate Data
Page 4 - COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Subdocument 6 - EX-21 - EX-21
Page 1 - Exhibit 21
Subdocument 7 - EX-23 - EX-23
Page 1 - Exhibit 23
Subdocument 8 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 9 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 10 - EX-32 - EX-32
Page 1 - Exhibit 32
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer